Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma in Situ × Educational Status × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 8 Breast Neoplasms 7 Lung Neoplasms 6 Prostatic Neoplasms 4 Obesity-Related Malignant Neoplasm 3 Neoplasm Metastasis 3 Lymphoma 3 Hematopoietic and Lymphatic System Neoplasm 3 Triple Negative Breast Neoplasms 2 Skin Carcinoma 2 Papillomavirus Infections 2 Hematologic Neoplasms 2 Anatomic Stage I Breast Cancer AJCC v8 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Testicular Neoplasms 1 Substance-Related Disorders 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Opioid-Related Disorders 1 Neoplasms 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 Glioblastoma 1 Genital Neoplasms, Female 1 Gastrointestinal Neoplasms 1

Interventions

dodecyl maltoside 2 Magnetic Resonance Imaging 2 Electrocardiography 2 Diphenhydramine 2 Acetaminophen 2 fludarabine phosphate 1 fludarabine 1 durvalumab 1 cemiplimab 1 aldesleukin 1 Tomography, X-Ray Computed 1 Respiratory Function Tests 1 Prochlorperazine 1 Positron-Emission Tomography 1 Ondansetron 1 O(6)-codeine methyl ether 1 Meperidine 1 Loperamide 1 Interleukin-2 1 Innovar 1 Indomethacin 1 Hydroxyzine 1 Histamine Antagonists 1 Granisetron 1 Droperidol 1 Doxylamine 1 Docetaxel 1 Diphenoxylate 1 Cystoscopy 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡